Sarira El‐Den
Biographic Data
| ID | 7844063 |
|---|---|
| NAME | Sarira El‐Den |
| GIVEN NAMES | Sarira |
| FAMILY NAME | El‐Den |
| SIGNATURE | EL DEN S |
| AFFILIATIONS | The University of Sydney |
| ORCID | 0000-0001-7500-3351 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Caregivers’ Perspectives Regarding the Use of Psychotropic Medication in Children and Young Adults
Side Effects of Psychotropic Medications Experienced by a Community Sample of People Living With Severe and Persistent Mental Illness
BACKGROUND: Psychotropic medications are a common treatment modality for people living with severe and persistent mental illness (SPMI). While effective in reducing relapse and hospitalisation, psychotropic medications cause numerous side effects, varying in nature and severity. Identification and management of side effects is crucial in the ongoing management of SPMI. OBJECTIVE: To characterise the side effects of psychotropic medications, exper…
Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness
BACKGROUND: Person-centred goal planning is increasingly being incorporated into healthcare interventions. People experiencing severe and persistent mental illnesses (SPMIs) have high levels of co-occurring health conditions, reducing their life expectancy when compared with the general population. As medications are commonly used in the treatment of SPMIs, community pharmacists are well-placed to support the health and wellbeing of this populati…
Psychological distress in community-dwelling individuals living with severe and persistent mental illness
OBJECTIVES: To explore psychological distress levels, using the validated Kessler 6 (K6), as well as the relationship between demographics and K6 scores, and incidence of mental health crises in a cohort of community-dwelling people living with severe and persistent mental illness (SPMI). METHODS: People living with SPMI taking antipsychotic or mood stabiliser medications were recruited from Australian community pharmacies between September 2020 …
Healthcare professionals’ knowledge, confidence and attitudes in relation to psychosis care
A training programme for community pharmacists to support people living with severe and persistent mental illness
Objective: The Bridging the Gap Between Physical and Mental Illness in Community Pharmacy ( PharMIbridge) randomised controlled trial (RCT) aims to test the effectiveness of a pharmacist-led support service in improving medication adherence, and the physical and mental health of people living with severe and persistent mental illness compared to a standard medication review service. Method: Using the six-step intervention mapping (IM) framework, …
Perinatal Women’s Views of Pharmacist-Delivered Perinatal Depression Screening
Internationally, 20% of women experience perinatal depression (PND). Healthcare providers including general practitioners and midwives are critical in providing PND screening and support; however, the current workforce is unable to meet growing demands for PND care. As accessible and trusted primary healthcare professionals, pharmacists could provide PND care to complement existing services, thereby contributing to early detection and interventio…
Confirmatory Factor Analysis of the Kessler-6 Psychological Distress (K6) Scale in a Community Sample of People Living with Severe and Persistent Mental Illness
No prominent works on this page.
A training programme for community pharmacists to support people living with severe and persistent mental illness
Objective: The Bridging the Gap Between Physical and Mental Illness in Community Pharmacy ( PharMIbridge) randomised controlled trial (RCT) aims to test the effectiveness of a pharmacist-led support service in improving medication adherence, and the physical and mental health of people living with severe and persistent mental illness compared to a standard medication review service. Method: Using the six-step intervention mapping (IM) framework, …
Perinatal Women’s Views of Pharmacist-Delivered Perinatal Depression Screening
Internationally, 20% of women experience perinatal depression (PND). Healthcare providers including general practitioners and midwives are critical in providing PND screening and support; however, the current workforce is unable to meet growing demands for PND care. As accessible and trusted primary healthcare professionals, pharmacists could provide PND care to complement existing services, thereby contributing to early detection and interventio…
Confirmatory Factor Analysis of the Kessler-6 Psychological Distress (K6) Scale in a Community Sample of People Living with Severe and Persistent Mental Illness
Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness
BACKGROUND: Person-centred goal planning is increasingly being incorporated into healthcare interventions. People experiencing severe and persistent mental illnesses (SPMIs) have high levels of co-occurring health conditions, reducing their life expectancy when compared with the general population. As medications are commonly used in the treatment of SPMIs, community pharmacists are well-placed to support the health and wellbeing of this populati…
Psychological distress in community-dwelling individuals living with severe and persistent mental illness
OBJECTIVES: To explore psychological distress levels, using the validated Kessler 6 (K6), as well as the relationship between demographics and K6 scores, and incidence of mental health crises in a cohort of community-dwelling people living with severe and persistent mental illness (SPMI). METHODS: People living with SPMI taking antipsychotic or mood stabiliser medications were recruited from Australian community pharmacies between September 2020 …
Healthcare professionals’ knowledge, confidence and attitudes in relation to psychosis care
Side Effects of Psychotropic Medications Experienced by a Community Sample of People Living With Severe and Persistent Mental Illness
BACKGROUND: Psychotropic medications are a common treatment modality for people living with severe and persistent mental illness (SPMI). While effective in reducing relapse and hospitalisation, psychotropic medications cause numerous side effects, varying in nature and severity. Identification and management of side effects is crucial in the ongoing management of SPMI. OBJECTIVE: To characterise the side effects of psychotropic medications, exper…
Caregivers’ Perspectives Regarding the Use of Psychotropic Medication in Children and Young Adults
Medicine (6 works) · Psychiatry (5 works) · Psychology (5 works) · Mental health (4 works) · Schizophrenia research and treatment (4 works) · Clinical Psychology (3 works) · Mental Health Treatment and Access (3 works) · Mental illness (3 works) · Nursing (3 works) · Pharmacist (3 works)